Ofev Side Effects
Generic name: nintedanib
Note: This document contains side effect information about nintedanib. Some dosage forms listed on this page may not apply to the brand name Ofev.
Applies to nintedanib: oral capsule.
Serious side effects of Ofev
Along with its needed effects, nintedanib (the active ingredient contained in Ofev) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking nintedanib:
More common
- Dark urine
- diarrhea
- loss of appetite
- nausea
- pain or tenderness in the upper stomach
- pale stools
- severe stomach pain
- vomiting
- yellow eyes or skin
Less common
- Black, tarry stools
- blood in the urine
- blurred vision
- bruising or purple areas on the skin
- chest pain or discomfort
- coughing up blood
- decreased alertness
- dizziness
- headache
- irregular heartbeat
- joint pain or swelling
- nervousness
- nosebleeds
- pain in the chest, groin, or legs, especially calves of the legs
- pain or discomfort in the arms, jaw, back, or neck
- pounding in the ears
- severe headaches of sudden onset
- slow or fast heartbeat
- stomach swelling
- sudden loss of coordination
- sudden onset of slurred speech
- sudden vision changes
- sweating
- trouble breathing
Incidence not known
- Bleeding gums
- bloating
- chills
- cloudy urine
- constipation
- difficult or painful urination
- fast heartbeat
- fever
- indigestion
- pains in the stomach, side, or abdomen, possibly radiating to the back
- pinpoint red spots on the skin
- sudden increase or decrease in amount of urine
- swelling of face, feet, or lower legs
- unusual bleeding or bruising
- weight gain
Other side effects of Ofev
Some side effects of nintedanib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Less common
- Depression
- dry skin and hair
- feeling cold
- hair loss
- hoarseness or husky voice
- muscle cramps and stiffness
- slow heartbeat
- unusual tiredness or weakness
For Healthcare Professionals
Applies to nintedanib: oral capsule.
General
The most common adverse reactions (incidence greater than 5%) included diarrhea, nausea, abdominal pain, vomiting, liver enzyme elevation, decreased appetite, headache, decreased weight, and hypertension.[Ref]
Cardiovascular
Common (1% to 10%): Hypertension, arterial thromboembolic events, venous thromboembolism
Uncommon (0.1% to 1%): Myocardial infarction
Frequency not reported: Aneurysms and artery dissections
Dermatologic
Very common (10% or more): Skin ulcer (18%)
Common (1% to 10%): Alopecia, rash
Uncommon (0.1% to 1%): Pruritus
Endocrine
Common (1% to 10%): Hypothyroidism
Gastrointestinal
Very common (10% or more): Diarrhea (up to 76%), nausea (up to 32%), vomiting (up to 25%), abdominal/esophageal pain (up to 18%), mucositis
Common (1% to 10%): Constipation
Uncommon (0.1% to 1%): Pancreatitis, colitis
Postmarketing reports: Gastrointestinal perforation
Hematologic
Very common (10% or more): Neutropenia (up to 13.8%), decreased hemoglobin (up to 11.2%)
Common (1% to 10%): Bleeding, febrile neutropenia
Uncommon (0.1% to 1%): Thrombocytopenia
Postmarketing reports: Bleeding events
Hepatic
Very common (10% or more): Liver enzyme elevation (up to 14%), increased ALT
Common (1% to 10%): Hyperbilirubinemia, increased ALT, increased GGT, increased blood alkaline phosphatase
Uncommon (0.1% to 1%): Drug induced liver injury
Metabolic
Very common (10% or more): Electrolyte imbalance
Uncommon (0.1% to 1%): Dehydration
Musculoskeletal
Common (1% to 10%): Back pain
Nervous system
Very common (10% or more): Peripheral neuropathy
Common (1% to 10%): Headache, dizziness
Other
Very common (10% or more): Decreased weight (up to 12%), fatigue (up to 11%), Decreased appetite (up to 11%)
Common (1% to 10%): Pyrexia, sepsis, abscesses
Renal
Uncommon (0.1% to 1%): Renal failure
Postmarketing reports: Proteinuria
Respiratory
Very common (10% or more): Cough (up to 15.2%)
Frequently asked questions
- What food should I avoid while taking Ofev?
- How long does it take for Ofev to start working?
- Why does Ofev cause diarrhea?
- Can Ofev and Esbriet be given together?
More about Ofev (nintedanib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (20)
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
References
1. (2022) "Product Information. Ofev (nintedanib)." Boehringer Ingelheim
2. (2024) "Product Information. Ofev (nintedanib)." Boehringer Ingelheim Pty Ltd
3. (2023) "Product Information. Ofev (nintedanib)." Boehringer Ingelheim Ltd
4. (2023) "Product Information. Vargatef (nintedanib)." Boehringer Ingelheim Ltd
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.